

100% closure up to
6 months,
86% closure at 1 year

Prospective

Theivacumar,
2009153

Patients/Limbs

Intervention

Comparison

Below-knee-GSV
none
RFA or below-kneeGSV EVLA plus
minus stripping

Bradbury,
2010218

Primary disease: 977 (868 C2/3 disease)
patients,